Article Details

Omalizumab Allergic Asthma Benefit Dependent on Pathway Metrics

Retrieved on: 2021-06-16 11:06:35

Tags for this article:

Click the tags to see associated articles and topics

Omalizumab Allergic Asthma Benefit Dependent on Pathway Metrics. View article details on hiswai:

Excerpt

... the monoclonal antibody omalizumab plus anti-immunoglobin therapy were ... Non-T (NANT) cells were verified and treated with specific antibodies.

Article found on: www.hcplive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up